New York Lab Pushes for Large-Scale Controlled Substance Manufacturing
Published Date: 7/17/2025
Notice
Summary
Curia New York, Inc. wants to become an official bulk maker of certain controlled drugs. This means they’ll be allowed to produce large amounts of these substances legally. If approved, this could impact companies and regulators by adding a new player in the drug manufacturing scene, with no immediate cost or deadline changes announced.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in